Crossmark

Hyporesponsiveness to long-acting erythropoiesis-stimulating agent is related to the risk of cardiovascular disease and death in Japanese patients on chronic hemodialysis: observational cohort study

Crossref DOI link: https://doi.org/10.1186/s41100-021-00332-0

Published Online: 2021-03-17

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanaka, Kenichi https://orcid.org/0000-0003-4655-9355
Fujiwara, Momoko

Saito, Hirotaka

Iwasaki, Tsuyoshi

Oda, Akira

Watanabe, Shuhei

Kanno, Makoto

Kimura, Hiroshi

Tani, Yoshihiro

Asai, Jun

Suzuki, Hodaka

Sato, Keiji

Kazama, Junichiro James
License Information

Text and Data Mining valid from 2021-03-17

Version of Record valid from 2021-03-17
More Information

Article History

Received: 1 December 2020

Accepted: 9 March 2021

First Online: 17 March 2021

Declarations

:

: This study protocol complied with the Declaration of Helsinki and was approved by the ethics committee at Fukushima Medical University (acceptance no. 2069). All patients received an explanation of the procedures and possible risks of this study and gave their written, informed consent to participate in this study.

: Not applicable.

: The authors declare that they have no competing interest.

Document is current

Any future updates will be listed below